Abiopharma

News list

Driscoll Cindy 🟢 acquired 100.0K shares (1 derivative) of Climb Bio, Inc. (CLYM) at $3.81 Transaction Date: Jan 06, 2026 | Filing ID: 007662

Full text

News bot Jan. 8, 2026, 9:12 p.m.
🔍 Driscoll Cindy (Executive)

Company: Climb Bio, Inc. (CLYM)

Report Date: 2026-01-06
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 100,000
Detailed Transactions and Holdings:
- Acquired 100,000 shares of Stock Option (Right to Buy) at $3.81 per share (Derivative)
  Date: 2026-01-06 | Code: A | Expires: 2036-01-05 | equity_swap_involved: false | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This option was granted on January 6, 2026 (the "Grant Date"). The shares underlying the option are scheduled to vest with respect to 25% of the shares on the first anniversary of the Grant Date and the remainder are scheduled to vest in 36 equal monthly installments through January 6, 2030, subject to the Reporting Person's continued service.